查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1600449

抗菌药物敏感性测试市场：按产品类型、方法、类型、应用、最终用户 - 全球预测 2025-2030

Antimicrobial Susceptibility Testing Market by Product Type (Automated Products, Consumables, Manual Products), Method (Agar Dilution, Disks Diffusion, ETEST), Type, Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年抗菌药物敏感性测试市值为38.1亿美元，预计到2024年将达到40.2亿美元，复合年增长率为5.83%，预计到2030年将达到56.7亿美元。

抗菌药物敏感性测试 (AST) 是感染疾病管理的重要组成部分，可确定抗生素对细菌和真菌的有效性。抗生素抗药性威胁日益严重，强调了对 AST 的需求，而有效的抗菌治疗需要及时、准确的资讯。 AST 的应用范围广泛，包括指导适当治疗方法的临床环境、筛检新抗生素的药物研发以及监测抗药性模式的公共卫生监测。最终用途范围主要包括医院、诊断实验室、製药公司和研究机构。市场成长的推动因素包括感染疾病数量的增加、抗菌素抗药性意识的提高、检测方法的高科技创新以及政府的大力支持。最新的潜在机会在于开发快速自动化 AST 系统、与基因组测试整合以提高准确性，以及用于资料共用和分析的云端基础平台。为了利用这些优势，公司应该投资于用户友好且具有成本效益的诊断解决方案的研发，并加强与医疗保健提供者和研究机构的合作。然而，先进 AST 系统的高成本、复杂的监管流程以及资源匮乏环境中的存取受限等挑战正在阻碍市场成长。此外，微生物反应的可变性需要不断更新和检验测试方法。创新机会比比皆是，特别是在开发人工智慧驱动的预测模型和照护现场使用而客製化的携带式AST 设备方面。对个人化医疗的日益重视也为 AST 创新提供了一条充满希望​​的途径。 AST 市场呈现出动态性，其成长潜力与生物技术和资讯学的进步密切相关，微生物抗药性的新兴市场模式也在不断发展，从而需要采取积极的策略来维持和加速这一市场开拓。

主要市场统计
基准年[2023] 38.1亿美元
预测年份 [2024] 40.2亿美元
预测年份 [2030] 56.7亿美元
复合年增长率（%） 5.83%

市场动态：快速发展的抗菌药物敏感性测试市场的关键市场洞察

供需的动态交互作用正在改变抗菌药物敏感性测试市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 抗菌药物敏感性测试在医疗决策中的重要性
    • 政府积极努力控制和预防感染疾病
  • 市场限制因素
    • 抗菌药敏试剂套件高成本且缺乏熟练的专业人员
  • 市场机会
    • 使用奈米颗粒进行抗菌敏感性测试的持续研究
    • 引进新基因组鑑定方法并推出抗菌药物检测套组
  • 市场挑战
    • 关于产品召回的发生和抗菌药物敏感性测试商业化的严格规定

波特五力：开拓抗菌药物敏感性测试市场的策略工具

波特的五力框架是了解抗菌药物敏感性测试市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解抗菌药敏感性测试市场的外部影响

外部宏观环境因素在塑造抗菌药物敏感性测试市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解抗菌药物敏感性测试市场的竞争格局

对抗菌药物敏感性测试市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵抗菌药物敏感性测试市场供应商的绩效评估

FPNV定位矩阵是评估抗菌药物敏感性测试市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。四个象限清楚且准确地划分供应商，帮助使用者辨识最能满足其策略目标的合作伙伴和解决方案。

本报告提供了涵盖关键重点领域的全面市场分析：

1. 市场渗透率：对当前市场环境的详细回顾，包括行业主要企业的大量资料。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 抗菌药物敏感性测试在医疗决策中的重要性
      • 旨在预防和根除感染疾病的有利政府倡议
    • 抑制因素
      • 抗菌药物敏感性检测套组高成本且缺乏熟练的专业人员
    • 机会
      • 正在进行的基于奈米颗粒的抗菌药敏测试的研究
      • 引进新基因组鑑定方法并推出抗菌药敏检测套组
    • 任务
      • 关于产品召回和抗菌药物敏感性测试商业化的严格规定
  • 市场区隔分析
    • 产品类型：用于感染疾病早期诊断和治疗的自动化工具和耗材的进展
    • 方法：开发定性 AST 技术，提高测试精度
    • 类型：对侵袭性真菌感染疾病认识的提高导致抗真菌药物敏试验取得重大进展
    • 应用：AST 在临床诊断、药物发现和开发中的快速和极端应用
    • 最终使用者： AST 在医院和诊断实验室中广泛使用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章抗生素敏感性测试市场：依产品类型

  • 自动化产品
  • 消耗品
  • 手动产品
    • 最低抑菌浓度（MIC）测试纸
    • 感光盘
    • 感光板

第七章抗菌药物敏感性测试市场：依方法

  • 琼脂稀释液
  • 圆盘扩散
  • ETEST
  • 基因型鉴定方法
  • 快速自动化方法

第八章抗生素敏感性测试市场：按类型

  • 抗生素敏感性测试
  • 抗真菌药物敏感性试验
  • 抗寄生虫药敏试验

第九章抗菌药物敏感性测试市场：依应用分类

  • 临床诊断
  • 药物发现与开发
  • 流行病学

第10章抗菌药物敏感性测试市场：依最终用户分类

  • 合约调查机构
  • 医院和诊断中心
  • 製药/生物技术
  • 研究/学术机构

第十一章美洲抗菌药物敏感性测试市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太地区抗菌药物敏感性测试市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲抗菌药物敏感性测试市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Strathclyde 衍生公司 Microplate dx 获得 250 万英镑资金筹措
    • Creative Diagnostics 宣布推出新的抗菌药物敏感性测试服务
    • Sysmex 在欧洲推出世界上第一个就地检验系统，只需 30 分钟即可测试抗菌药物敏感性
    • Pattern Biosciences 获得 2870 万美元 C 轮资金筹措
    • JMI 实验室和生物梅里埃合作进行抗菌药物抗药性诊断
    • Gradientec 欢迎商业伙伴的投资
    • 生物梅里埃提交 Vitek Reveil 申请 FDA核准
    • Selux Diagnostics 获得 FDA核准进行快速抗生素敏感性测试
    • FDA核准快速抗生素敏感性测试
    • FASTinov 与 Beckman Coulter Life Sciences 合作，为临床微生物实验室带来突破性的超快 2h-AST 技术。
    • Registel 筹集 850 万瑞士法郎完成抗生素敏感性测试临床试验
    • 自动化和全电子抗生素敏感性测试开发商 Avails Medical (East) 宣布过渡到下一阶段的 Carb-X津贴。
    • BD 与 Accelerate Diagnostics 建立商业合作伙伴关係
    • Bio-Rad 收购 Curiosity Diagnostics

公司名单

  • Creative Diagnostics
  • Bio-Rad Laboratories, Inc.
  • Biosafe Ltd.
  • BioMerieux SA
  • Laboratorios Conda, SA
  • Genefluidics, Inc.
  • Pfizer Inc.
  • F. Hoffmann-La Roche AG
  • Danaher Corporation
  • Zhuhai DL Biotech Co., Ltd.
  • Becton, Dickinson and Company
  • Launch Diagnostics Limited
  • Alifax Srl
  • Liofilchem Srl
  • Synoptics Group
  • QuantaMatrix Inc.
  • Himedia Laboratories Private Limited
  • Mast Group Ltd.
  • ELITech Group SAS
  • INTEGRA Biosciences AG
  • Eurofins Scientific SE
  • Accelerate Diagnostics, Inc.
  • Thermo Fisher Scientific Inc.
  • Rapid Test Methods Ltd.
  • Erba Lachema sro
  • Bruker Corporation
  • Leading Biology, Inc.
  • BIOANALYSE TIbbi Malz. San. ve Tic. Ltd. Sti.
  • MP Biomedicals, LLC
  • Resistell AG
  • Qiagen NV
Product Code: MRR-464C422F4BD3

The Antimicrobial Susceptibility Testing Market was valued at USD 3.81 billion in 2023, expected to reach USD 4.02 billion in 2024, and is projected to grow at a CAGR of 5.83%, to USD 5.67 billion by 2030.

Antimicrobial Susceptibility Testing (AST) is a critical component in infectious disease management, involving the determination of the efficacy of antibiotics on bacteria or fungi. The necessity of AST is underscored by the growing threats of antibiotic resistance, requiring timely and accurate information for effective antimicrobial therapy. Applications of AST are broad, encompassing clinical settings to guide appropriate treatment regimens, pharmaceutical research and development to screen for new antimicrobials, and public health surveillance to monitor resistance patterns. The end-use scope primarily involves hospitals, diagnostic labs, pharmaceutical companies, and research institutions. Market growth is influenced by factors such as increasing incidences of infectious diseases, rising awareness of antimicrobial resistance, advanced technological innovations in testing methods, and substantial government support. The latest potential opportunities lie in the development of rapid, automated AST systems, integration with genomic testing to enhance precision, and cloud-based platforms for data sharing and analysis. To capitalize on these, businesses should invest in research and development of user-friendly, cost-effective diagnostic solutions and enhance collaborations with healthcare providers and research bodies. However, market growth is hindered by challenges such as high costs of advanced AST systems, complex regulatory processes, and the limited accessibility in low-resource settings. Furthermore, variability in microbial response necessitates continuous updates and validation of testing methods. Innovation opportunities are abundant, particularly in the development of AI-driven predictive models and portable AST devices tailored for point-of-care use. Increased emphasis on personalized medicine also offers a promising avenue for AST innovation. The AST market exhibits a dynamic nature, with growth potential tightly linked to advancements in biotechnology and informatics, alongside evolving patterns in microbial resistance, necessitating continuous adaptation and proactive strategies to sustain and accelerate market development.

KEY MARKET STATISTICS
Base Year [2023] USD 3.81 billion
Estimated Year [2024] USD 4.02 billion
Forecast Year [2030] USD 5.67 billion
CAGR (%) 5.83%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Antimicrobial Susceptibility Testing Market

The Antimicrobial Susceptibility Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Importance of antimicrobial susceptibility testing in medical decision-making
    • Favorable government initiatives aiming to combat and prevent infectious diseases
  • Market Restraints
    • High cost of antimicrobial susceptibility kits and lack of skilled professionals
  • Market Opportunities
    • Ongoing research on nanoparticles-based antimicrobial susceptibility testing
    • Introduction of new genomic identification methods and launch of antimicrobial susceptibility test kits
  • Market Challenges
    • Incidence of product recalls and strict regulations regarding antimicrobial susceptibility testing commercialization

Porter's Five Forces: A Strategic Tool for Navigating the Antimicrobial Susceptibility Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Antimicrobial Susceptibility Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Antimicrobial Susceptibility Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Antimicrobial Susceptibility Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Antimicrobial Susceptibility Testing Market

A detailed market share analysis in the Antimicrobial Susceptibility Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Antimicrobial Susceptibility Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Antimicrobial Susceptibility Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Antimicrobial Susceptibility Testing Market, highlighting leading vendors and their innovative profiles. These include Creative Diagnostics, Bio-Rad Laboratories, Inc., Biosafe Ltd., BioMerieux SA, Laboratorios Conda, S.A., Genefluidics, Inc., Pfizer Inc., F. Hoffmann-La Roche AG, Danaher Corporation, Zhuhai DL Biotech Co., Ltd., Becton, Dickinson and Company, Launch Diagnostics Limited, Alifax S.r.l., Liofilchem S.r.l., Synoptics Group, QuantaMatrix Inc., Himedia Laboratories Private Limited, Mast Group Ltd., ELITech Group SAS, INTEGRA Biosciences AG, Eurofins Scientific SE, Accelerate Diagnostics, Inc., Thermo Fisher Scientific Inc., Rapid Test Methods Ltd., Erba Lachema s.r.o., Bruker Corporation, Leading Biology, Inc., BIOANALYSE TIbbi Malz. San. ve Tic. Ltd. Sti., MP Biomedicals, LLC, Resistell AG, and Qiagen N.V..

Market Segmentation & Coverage

This research report categorizes the Antimicrobial Susceptibility Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Automated Products, Consumables, and Manual Products. The Manual Products is further studied across Minimum Inhibitory Concentration (MIC) Strips, Susceptibility Discs, and Susceptibility Plates.
  • Based on Method, market is studied across Agar Dilution, Disks Diffusion, ETEST, Genotyping Methods, and Rapid Automation Method.
  • Based on Type, market is studied across Antibacterial Susceptibility Testing, Antifungal Susceptibility Testing, and Antiparasitic Susceptibility Testing.
  • Based on Application, market is studied across Clinical Diagnostics, Drug Discovery & Development, and Epidemiology.
  • Based on End-User, market is studied across Contract Research Organizations, Hospital & Diagnostic Centers, Pharmaceutical & Biotechnology, and Research & Academic Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Importance of antimicrobial susceptibility testing in medical decision-making
      • 5.1.1.2. Favorable government initiatives aiming to combat and prevent infectious diseases
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of antimicrobial susceptibility kits and lack of skilled professionals
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing research on nanoparticles-based antimicrobial susceptibility testing
      • 5.1.3.2. Introduction of new genomic identification methods and launch of antimicrobial susceptibility test kits
    • 5.1.4. Challenges
      • 5.1.4.1. Incidence of product recalls and strict regulations regarding antimicrobial susceptibility testing commercialization
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product Type: Advancement in the automated tools and consumables for early diagnosing and treatment of the infectious diseases
    • 5.2.2. Method: Development of qualitative AST techniques with increased accuracy of the tests
    • 5.2.3. Type: Significant advancements in antifungal susceptibility testing due to heightened awareness of invasive fungal infections
    • 5.2.4. Application: Rapid and extreme utilization of the AST in clinical diagnostics and drug discovery and development
    • 5.2.5. End-User: Extensive use of AST in hospitals and diagnostic laboratories
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Antimicrobial Susceptibility Testing Market, by Product Type

  • 6.1. Introduction
  • 6.2. Automated Products
  • 6.3. Consumables
  • 6.4. Manual Products
    • 6.4.1. Minimum Inhibitory Concentration (MIC) Strips
    • 6.4.2. Susceptibility Discs
    • 6.4.3. Susceptibility Plates

7. Antimicrobial Susceptibility Testing Market, by Method

  • 7.1. Introduction
  • 7.2. Agar Dilution
  • 7.3. Disks Diffusion
  • 7.4. ETEST
  • 7.5. Genotyping Methods
  • 7.6. Rapid Automation Method

8. Antimicrobial Susceptibility Testing Market, by Type

  • 8.1. Introduction
  • 8.2. Antibacterial Susceptibility Testing
  • 8.3. Antifungal Susceptibility Testing
  • 8.4. Antiparasitic Susceptibility Testing

9. Antimicrobial Susceptibility Testing Market, by Application

  • 9.1. Introduction
  • 9.2. Clinical Diagnostics
  • 9.3. Drug Discovery & Development
  • 9.4. Epidemiology

10. Antimicrobial Susceptibility Testing Market, by End-User

  • 10.1. Introduction
  • 10.2. Contract Research Organizations
  • 10.3. Hospital & Diagnostic Centers
  • 10.4. Pharmaceutical & Biotechnology
  • 10.5. Research & Academic Institutes

11. Americas Antimicrobial Susceptibility Testing Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Antimicrobial Susceptibility Testing Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Antimicrobial Susceptibility Testing Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Strathclyde spin-out Microplate dx secures GBP 2.5 million in funding
    • 14.3.2. Creative Diagnostics Announces New Antimicrobial Susceptibility Testing Services
    • 14.3.3. Sysmex Launches World's First Point-of-Care Testing System in Europe to Detect Antimicrobial Susceptibility in Just 30 Minutes
    • 14.3.4. Pattern Bioscience Secures USD 28.7 Million in Series C Financing
    • 14.3.5. JMI Laboratories and bioMerieux Enter Antimicrobial Resistance Diagnostics Partnership
    • 14.3.6. Gradientech Welcomes Investment From Commercial Partner
    • 14.3.7. bioMerieux's Submits Vitek Reveal to FDA for Clearance
    • 14.3.8. Selux Diagnostics Secures FDA Approval For Its Rapid Antibiotic Susceptibility Test
    • 14.3.9. FDA clears rapid antibiotic susceptibility test
    • 14.3.10. FASTinov Collaborates With Beckman Coulter Life Sciences To Bring Ultra-Rapid 2h-AST Disruptive Technology To Clinical Microbiology Laboratories
    • 14.3.11. Resistell raises CHF 8.5 million to complete clinical trials for antibiotic susceptibility testing
    • 14.3.12. Avails Medical, A Developer 0f Automated and Fully Electrical Antibiotic Susceptibility Testing (East) has Announced the Transition to The Next Phase of Its Carb-X Grant.
    • 14.3.13. BD Enters Commercial Collaboration With Accelerate Diagnostics
    • 14.3.14. Bio-Rad Acquires Curiosity Diagnostics

Companies Mentioned

  • 1. Creative Diagnostics
  • 2. Bio-Rad Laboratories, Inc.
  • 3. Biosafe Ltd.
  • 4. BioMerieux SA
  • 5. Laboratorios Conda, S.A.
  • 6. Genefluidics, Inc.
  • 7. Pfizer Inc.
  • 8. F. Hoffmann-La Roche AG
  • 9. Danaher Corporation
  • 10. Zhuhai DL Biotech Co., Ltd.
  • 11. Becton, Dickinson and Company
  • 12. Launch Diagnostics Limited
  • 13. Alifax S.r.l.
  • 14. Liofilchem S.r.l.
  • 15. Synoptics Group
  • 16. QuantaMatrix Inc.
  • 17. Himedia Laboratories Private Limited
  • 18. Mast Group Ltd.
  • 19. ELITech Group SAS
  • 20. INTEGRA Biosciences AG
  • 21. Eurofins Scientific SE
  • 22. Accelerate Diagnostics, Inc.
  • 23. Thermo Fisher Scientific Inc.
  • 24. Rapid Test Methods Ltd.
  • 25. Erba Lachema s.r.o.
  • 26. Bruker Corporation
  • 27. Leading Biology, Inc.
  • 28. BIOANALYSE TIbbi Malz. San. ve Tic. Ltd. Sti.
  • 29. MP Biomedicals, LLC
  • 30. Resistell AG
  • 31. Qiagen N.V.

LIST OF FIGURES

  • FIGURE 1. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY AUTOMATED PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MINIMUM INHIBITORY CONCENTRATION (MIC) STRIPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY SUSCEPTIBILITY DISCS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY SUSCEPTIBILITY PLATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY AGAR DILUTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY DISKS DIFFUSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ETEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY GENOTYPING METHODS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY RAPID AUTOMATION METHOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANTIBACTERIAL SUSCEPTIBILITY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANTIFUNGAL SUSCEPTIBILITY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANTIPARASITIC SUSCEPTIBILITY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY EPIDEMIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 82. AUSTRALIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 87. CHINA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 88. CHINA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. CHINA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. CHINA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 93. INDIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 94. INDIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. INDIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. INDIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 99. INDONESIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 100. INDONESIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. INDONESIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. INDONESIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 105. JAPAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 106. JAPAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. JAPAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. JAPAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 111. MALAYSIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 112. MALAYSIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. MALAYSIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. MALAYSIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 118. PHILIPPINES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. PHILIPPINES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 123. SINGAPORE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 124. SINGAPORE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SINGAPORE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SINGAPORE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH KOREA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH KOREA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 135. TAIWAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 136. TAIWAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. TAIWAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. TAIWAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 141. THAILAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 142. THAILAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. THAILAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. THAILAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 147. VIETNAM ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 148. VIETNAM ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. VIETNAM ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. VIETNAM ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 160. DENMARK ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 161. DENMARK ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. DENMARK ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. DENMARK ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 166. EGYPT ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 167. EGYPT ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. EGYPT ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. EGYPT ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 172. FINLAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 173. FINLAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. FINLAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. FINLAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 178. FRANCE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 179. FRANCE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. FRANCE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. FRANCE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 184. GERMANY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 185. GERMANY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. GERMANY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. GERMANY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 190. ISRAEL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 191. ISRAEL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. ISRAEL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. ISRAEL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 196. ITALY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 197. ITALY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. ITALY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 199. ITALY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 202. NETHERLANDS ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. NETHERLANDS ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 205. NETHERLANDS ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 208. NIGERIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 209. NIGERIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. NIGERIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 211. NIGERIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 214. NORWAY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 215. NORWAY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. NORWAY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. NORWAY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 220. POLAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 221. POLAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. POLAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 223. POLAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 226. QATAR ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 227. QATAR ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. QATAR ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 229. QATAR ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 232. RUSSIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 233. RUSSIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. RUSSIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 235. RUSSIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 238. SAUDI ARABIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 240. SAUDI ARABIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH AFRICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 246. SOUTH AFRICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 247. SOUTH AFRICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 250. SPAIN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 251. SPAIN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 252. SPAIN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 253. SPAIN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 256. SWEDEN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 257. SWEDEN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 258. SWEDEN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 259. SWEDEN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 262. SWITZERLAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 264. SWITZERLAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 265. SWITZERLAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 268. TURKEY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 269. TURKEY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 270. TURKEY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 271. TURKEY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED ARAB EMIRATES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED KINGDOM ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 282. UNITED KINGDOM ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 283. UNITED KINGDOM ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 284. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 285. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, FPNV POSITIONING MATRIX, 2023